skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:060466/0386   Pages: 13
Recorded: 07/08/2022
Attorney Dkt #:376464.VARIOUS
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 5
1
Patent #:
Issue Dt:
09/21/2010
Application #:
11347115
Filing Dt:
02/02/2006
Publication #:
Pub Dt:
07/13/2006
Title:
GUANYLATE CYCLASE RECEPTOR AGONISTS FOR THE TREATMENT OF TISSUE INFLAMMATION AND CARCINOGENESIS
2
Patent #:
Issue Dt:
10/11/2011
Application #:
12504288
Filing Dt:
07/16/2009
Publication #:
Pub Dt:
04/15/2010
Title:
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
3
Patent #:
Issue Dt:
02/14/2012
Application #:
12763707
Filing Dt:
04/20/2010
Publication #:
Pub Dt:
09/01/2011
Title:
GUANYLATE CYCLASE RECEPTOR AGONISTS FOR THE TREATMENT OF TISSUE INFLAMMATION AND CARCINOGENESIS
4
Patent #:
Issue Dt:
07/28/2015
Application #:
13513224
Filing Dt:
08/01/2012
Publication #:
Pub Dt:
11/15/2012
Title:
Method of Inhibiting Bile Acid Absorption by Administering An Agonist of a Guanylate Cyclase Receptor
5
Patent #:
Issue Dt:
02/23/2016
Application #:
14528257
Filing Dt:
10/30/2014
Publication #:
Pub Dt:
02/26/2015
Title:
AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
Assignor
1
Exec Dt:
03/04/2019
Assignee
1
3013 LAKE DRIVE
CITYWEST BUSINESS CAMPUS
DUBLIN, IRELAND 24
Correspondence name and address
DOMINGOS J. SILVA
SAUL EWING ARNSTEIN & LEHR LLP
1500 MARKET STREET, 38TH FLOOR
PHILADELPHIA, PA 19102

Search Results as of: 04/29/2024 04:39 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT